Description:XL-888, with the CAS number 1149705-71-4, is a chemical compound that has been studied primarily for its potential applications in the field of oncology. It is classified as a small molecule inhibitor, specifically targeting certain kinases involved in cellular signaling pathways that regulate cell growth and survival. The compound exhibits properties that may contribute to its effectiveness in inhibiting tumor growth and proliferation. XL-888 has been evaluated in various preclinical studies, demonstrating its ability to interfere with the activity of specific proteins that are often overexpressed in cancer cells. Its mechanism of action typically involves the disruption of signaling cascades that are crucial for cancer cell survival. Additionally, the compound's pharmacokinetic profile, including absorption, distribution, metabolism, and excretion, is essential for determining its therapeutic potential and safety in clinical settings. As research continues, further insights into its efficacy and possible side effects will be critical for its development as a therapeutic agent.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
![1,4-Benzenedicarboxamide, N1-[(3-endo)-8-[5-(cyclopropylcarbonyl)-2-pyridinyl]-8-azabicyclo[3.2.1]…](https://static.cymitquimica.com/products/IN/thumb/DA000FIA.jpg)
